Tag: FDA-approved neuroblastoma drugs 2023

Home / FDA-approved neuroblastoma drugs 2023

Categories

Eflornithine is approved by USFDA for adult and pediatric patients with high-risk neuroblastoma

The FDA approved eflornithine (IWILFIN, USWM, LLC) on December 13, 2023, to lower the risk of relapse in adults and children with high-risk neuroblastoma (HRNB) who had a partial response to previou...
fda-approved-neuroblastoma-drugs-2023

Scan the code